For the quarter ending 2025-09-30, MLSS made $2,360,117 in revenue. -$1,153,959 in net income. Net profit margin of -48.89%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Product sales, net | 2,360,117 | 2,323,466 | 2,232,420 | 2,513,805 |
| Cost of products sold | 719,247 | 705,860 | 584,985 | 677,585 |
| Gross profit | 1,640,870 | 1,617,606 | 1,647,435 | 1,836,220 |
| Selling, general and administrative expenses | 2,739,011 | 3,030,952 | 3,256,728 | 3,064,769 |
| Research and development expenses | 16,226 | 51,789 | 369,120 | 232,056 |
| Depreciation and amortization expense | 20,104 | 19,496 | 19,440 | 8,574 |
| Total operating expenses | 2,775,341 | 3,102,237 | 3,645,288 | 3,305,399 |
| Loss from operations | -1,134,471 | -1,484,631 | -1,997,853 | -1,469,179 |
| Interest income, net | - | 1,521 | 3,267 | 8,008 |
| Gain on sale of net operating losses | - | 0 | - | - |
| Interest (expense) income, net | -19,488 | - | - | - |
| Loss before provision for income taxes | -1,153,959 | -1,483,110 | -1,994,586 | -1,461,171 |
| Provision for income taxes | - | 0 | - | - |
| Net loss | - | -1,483,110 | -1,994,586 | -1,461,171 |
| Net loss | -1,153,959 | - | - | -1,461,171 |
| Net loss per share applicable to common stockholders - basic | -0.01 | -0.02 | -0.02 | -0.02 |
| Net loss per share applicable to common stockholders - diluted | -0.01 | - | - | - |
| Weighted average shares outstanding and to be issued - basic | 82,322,910 | 82,049,984 | 81,854,512 | 79,966,833 |
| Weighted average shares outstanding and to be issued - diluted | 82,322,910 | - | - | - |
MILESTONE SCIENTIFIC INC. (MLSS)
MILESTONE SCIENTIFIC INC. (MLSS)